| Date Filed | Type | Description |
| 02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/10/2017 |
SC 13G/A
| EndoChoice Holdings, Inc. reports a 0% stake in ENDOCHOICE HOLDINGS, INC. |
| 02/02/2017 |
SC 13G/A
| ENVEST III LLC reports a 0% stake in EndoChoice Holdings, Inc. |
| 12/21/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 12/05/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 11/28/2016 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership [Amend] |
| 11/23/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/23/2016 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/22/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
| 11/22/2016 |
8-K
| Quarterly results |
| 11/22/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 11/18/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 11/07/2016 |
10-Q
| Quarterly Report for the period ended September 30, 2016 |
| 11/04/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/26/2016 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party [Amend] |
| 10/11/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 10/11/2016 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 10/07/2016 |
SC TO-T
| Form SC TO-T - Tender offer statement by Third Party |
| 10/07/2016 |
SC 14D9
| Form SC 14D9 - Solicitation, recommendation statements |
| 09/27/2016 |
SC14D9C
| Form SC14D9C - Written communication relating to third party tender offer |
| 09/27/2016 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits |
| 09/27/2016 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party |
| 08/11/2016 |
EFFECT
| Form EFFECT - Notice of Effectiveness |
| 08/09/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals [Amend] |
| 08/03/2016 |
8-K
| Quarterly results |
| 08/03/2016 |
10-Q
| Quarterly Report for the period ended June 30, 2016 |
| 05/05/2016 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 05/04/2016 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...|
Docs:
|
"EndoChoice® Announces William Enquist as New Chairman of the Board Alpharetta, GA., May 2, 2016 - EndoChoice Holdings, Inc. announced today that existing Board member William Enquist has been elevated to the position of Chairman of the Board of Directors. Scott Huennekens, who has served as Chairman since April 2015, will remain on the Board of Directors. Mr. Huennekens is stepping down as Chairman to focus on his position as President & Chief Executive Officer of recently formed Verb Surgical, an independent surgical solutions company that is a collaboration between Ethicon, a Johnson & Johnson medical devices company, and Google Life Sciences. Mark Gilreath, Founder and Chief Executive Officer of EndoChoice, said, “On behalf of EndoChoice’s Board I would like to thank Scott for his contr..." |
|
| 05/04/2016 |
8-K
| Form 8-K - Current report |
| 05/04/2016 |
10-Q
| Quarterly Report for the period ended May 4, 2016 |
| 03/21/2016 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/21/2016 |
10-K
| Annual Report for the period ended December 31, 2015 |
| 03/03/2016 |
8-K
| Form 8-K - Current report |
| 02/16/2016 |
SC 13G/A
| ENVEST III LLC reports a 7.1% stake in EndoChoice Holdings, Inc. |
|